Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
this is more of a supportive measure than an interaction concern
Journal of Gastroenterology, 58(9), 801-833
Its not just about the weightloss but about learning how to be healthy for life
Aphaia Pharma Headquarters: Switzerland Technology: oral glucose formulation Lead candidate: APH-012 As disruptions in the guts natural responses to food intake are linked to metabolic diseases, such as obesity, Swiss biotech company Aphaia Pharma has come up with a way to restore these said natural responses, different from conventional obesity therapies like GLP-1 agonists
US$ 21.36
US$ 29.07
US$ 28.73
US$ 22.89
